No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113590400-113595200 |
Enhancers |
Fetal Intestine Small |
intestine
|
2 |
chr2:113590600-113596000 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
3 |
chr2:113591200-113595000 |
Enhancers |
Fetal Intestine Large |
intestine
|
4 |
chr2:113591200-113600200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
5 |
chr2:113591600-113595000 |
Enhancers |
Adipose Nuclei |
Adipose
|
6 |
chr2:113591800-113595000 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
7 |
chr2:113592200-113595000 |
Enhancers |
Sigmoid Colon |
Sigmoid Colon
|
8 |
chr2:113592800-113597200 |
Weak transcription |
Liver |
Liver
|
9 |
chr2:113593400-113595000 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
10 |
chr2:113593400-113595000 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
11 |
chr2:113593400-113595000 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
12 |
chr2:113593800-113595000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
13 |
chr2:113593800-113595400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
14 |
chr2:113594000-113595000 |
Enhancers |
NH-A |
brain
|
15 |
chr2:113594000-113595000 |
Enhancers |
NHDF-Ad |
bronchial
|
16 |
chr2:113594000-113595400 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
17 |
chr2:113594000-113598000 |
Weak transcription |
Stomach Mucosa |
stomach
|
18 |
chr2:113594200-113595000 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
19 |
chr2:113594200-113595000 |
Enhancers |
Small Intestine |
intestine
|
20 |
chr2:113594200-113595000 |
Enhancers |
HUVEC |
blood vessel
|
21 |
chr2:113594400-113595000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
22 |
chr2:113594400-113595200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
23 |
chr2:113594400-113595200 |
Enhancers |
GM12878-XiMat |
blood
|
24 |
chr2:113594400-113595200 |
Enhancers |
Osteobl |
bone
|
25 |
chr2:113594400-113596000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
26 |
chr2:113594400-113596600 |
Weak transcription |
Rectal Mucosa Donor 29 |
rectum
|
27 |
chr2:113594400-113597200 |
Enhancers |
Primary B cells from cord blood |
blood
|
28 |
chr2:113594400-113598200 |
Enhancers |
HMEC |
breast
|
29 |
chr2:113594400-113600200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
30 |
chr2:113594400-113601200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
31 |
chr2:113594600-113595000 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
32 |
chr2:113594600-113595000 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
33 |
chr2:113594600-113595000 |
Bivalent Enhancer |
Muscle Satellite Cultured Cells |
--
|
34 |
chr2:113594600-113595000 |
Flanking Active TSS |
NHEK |
skin
|
35 |
chr2:113594600-113595200 |
Enhancers |
Spleen |
Spleen
|
36 |
chr2:113594600-113595200 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
37 |
chr2:113594600-113595400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
38 |
chr2:113594600-113596400 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
39 |
chr2:113594600-113597400 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
40 |
chr2:113594800-113595000 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
41 |
chr2:113594800-113595000 |
Enhancers |
Esophagus |
oesophagus
|
42 |
chr2:113594800-113595000 |
Flanking Active TSS |
Hela-S3 |
cervix
|
43 |
chr2:113594800-113595800 |
Weak transcription |
iPS-18 Cell Line |
embryonic stem cell
|